CO logo

Global Cord Blood (CO) Net Income

CO Annual Net Income

$78.00 M
+$2.99 M+3.98%

31 March 2022

CO Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CO Quarterly Net Income

$16.47 M
-$4.50 M-21.44%

31 March 2022

CO Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CO TTM Net Income

$77.97 M
-$3.21 M-3.96%

31 March 2022

CO TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CO Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.0%-16.3%+4.0%
3 y3 years+79.7%+22.1%+16.2%
5 y5 years+316.9%+199.3%+16.2%

CO Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall timeat high-22.0%-4.0%

Global Cord Blood Net Income History

DateAnnualQuarterlyTTM
Mar 2022
$78.00 M(+4.0%)
$16.47 M(-21.4%)
$77.97 M(-4.0%)
Dec 2021
-
$20.97 M(+8.0%)
$81.19 M(+4.4%)
Sept 2021
-
$19.42 M(-8.0%)
$77.80 M(+0.6%)
June 2021
-
$21.11 M(+7.2%)
$77.36 M(+3.2%)
Mar 2021
$75.02 M(+11.0%)
$19.69 M(+12.0%)
$74.94 M(+8.4%)
Dec 2020
-
$17.58 M(-7.4%)
$69.14 M(-4.2%)
Sept 2020
-
$18.98 M(+1.6%)
$72.15 M(+2.6%)
June 2020
-
$18.69 M(+34.5%)
$70.32 M(+4.2%)
Mar 2020
$67.58 M(+55.7%)
$13.89 M(-32.5%)
$67.52 M(+0.6%)
Dec 2019
-
$20.59 M(+20.0%)
$67.12 M(+21.1%)
Sept 2019
-
$17.15 M(+8.0%)
$55.40 M(+15.9%)
June 2019
-
$15.88 M(+17.7%)
$47.82 M(+10.0%)
Mar 2019
$43.40 M(+20.8%)
$13.50 M(+52.1%)
$43.48 M(+25.0%)
Dec 2018
-
$8.87 M(-7.3%)
$34.78 M(-4.6%)
Sept 2018
-
$9.57 M(-17.1%)
$36.47 M(-1.5%)
June 2018
-
$11.55 M(+140.7%)
$37.04 M(+4.1%)
Mar 2018
$35.92 M(+92.0%)
$4.80 M(-54.6%)
$35.57 M(-2.0%)
Dec 2017
-
$10.56 M(+4.2%)
$36.28 M(+7.3%)
Sept 2017
-
$10.14 M(+0.6%)
$33.83 M(+29.2%)
June 2017
-
$10.08 M(+83.1%)
$26.18 M(+41.4%)
Mar 2017
$18.71 M(+30.8%)
$5.50 M(-32.1%)
$18.51 M(+29.7%)
Dec 2016
-
$8.11 M(+224.8%)
$14.27 M(+1.5%)
Sept 2016
-
$2.50 M(+3.7%)
$14.05 M(-3.3%)
June 2016
-
$2.41 M(+91.0%)
$14.53 M(+1.6%)
Mar 2016
$14.30 M(-17.4%)
$1.26 M(-84.0%)
$14.31 M(-9.2%)
Dec 2015
-
$7.89 M(+165.7%)
$15.76 M(+18.5%)
Sept 2015
-
$2.97 M(+36.1%)
$13.29 M(-9.8%)
June 2015
-
$2.18 M(-19.5%)
$14.74 M(-14.9%)
Mar 2015
$17.31 M
$2.71 M(-50.0%)
$17.33 M(-17.9%)
Dec 2014
-
$5.43 M(+22.8%)
$21.10 M(-1.1%)
Sept 2014
-
$4.42 M(-7.4%)
$21.34 M(+1.7%)
DateAnnualQuarterlyTTM
June 2014
-
$4.77 M(-26.4%)
$20.99 M(-2.7%)
Mar 2014
$21.56 M(+20.7%)
$6.48 M(+14.3%)
$21.57 M(+14.8%)
Dec 2013
-
$5.67 M(+39.5%)
$18.78 M(+1.6%)
Sept 2013
-
$4.07 M(-23.9%)
$18.49 M(+1.0%)
June 2013
-
$5.35 M(+44.6%)
$18.30 M(+2.5%)
Mar 2013
$17.86 M(-13.4%)
$3.70 M(-31.3%)
$17.86 M(-5.0%)
Dec 2012
-
$5.38 M(+38.6%)
$18.79 M(-4.2%)
Sept 2012
-
$3.88 M(-20.9%)
$19.61 M(+1.4%)
June 2012
-
$4.90 M(+6.0%)
$19.35 M(-6.1%)
Mar 2012
$20.61 M(+51.2%)
$4.63 M(-25.3%)
$20.60 M(+3.2%)
Dec 2011
-
$6.20 M(+71.3%)
$19.95 M(+13.1%)
Sept 2011
-
$3.62 M(-41.2%)
$17.64 M(+2.2%)
June 2011
-
$6.15 M(+54.4%)
$17.26 M(+26.2%)
Mar 2011
$13.64 M(+89.2%)
$3.98 M(+2.7%)
$13.68 M(+13.5%)
Dec 2010
-
$3.88 M(+19.7%)
$12.05 M(+8.5%)
Sept 2010
-
$3.24 M(+26.0%)
$11.11 M(+6.3%)
June 2010
-
$2.57 M(+9.1%)
$10.45 M(+45.1%)
Mar 2010
$7.21 M(-734.5%)
$2.36 M(-19.6%)
$7.20 M(+58.1%)
Dec 2009
-
$2.93 M(+13.4%)
$4.56 M(+722.3%)
Sept 2009
-
$2.59 M(-484.1%)
$554.00 K(-125.2%)
June 2009
-
-$673.30 K(+132.2%)
-$2.20 M(+48.2%)
Mar 2009
-
-$290.00 K(-72.9%)
-$1.48 M(+28.4%)
Dec 2008
-$1.14 M(-400.3%)
-$1.07 M(+541.0%)
-$1.16 M(-4704.0%)
Sept 2008
-
-$166.70 K(-497.9%)
$25.10 K(-91.3%)
June 2008
-
$41.90 K(+10.8%)
$286.90 K(-6.7%)
Mar 2008
-
$37.80 K(-66.3%)
$307.50 K(-19.6%)
Dec 2007
$378.20 K(>+9900.0%)
$112.10 K(+17.9%)
$382.70 K(+41.4%)
Sept 2007
-
$95.10 K(+52.2%)
$270.60 K(+54.2%)
June 2007
-
$62.50 K(-44.7%)
$175.50 K(+55.3%)
Mar 2007
-
$113.00 K
$113.00 K
Dec 2006
$2300.00
-
-

FAQ

  • What is Global Cord Blood annual net profit?
  • What is the all time high annual net income for Global Cord Blood?
  • What is Global Cord Blood annual net income year-on-year change?
  • What is Global Cord Blood quarterly net profit?
  • What is the all time high quarterly net income for Global Cord Blood?
  • What is Global Cord Blood quarterly net income year-on-year change?
  • What is Global Cord Blood TTM net profit?
  • What is the all time high TTM net income for Global Cord Blood?
  • What is Global Cord Blood TTM net income year-on-year change?

What is Global Cord Blood annual net profit?

The current annual net income of CO is $78.00 M

What is the all time high annual net income for Global Cord Blood?

Global Cord Blood all-time high annual net profit is $78.00 M

What is Global Cord Blood annual net income year-on-year change?

Over the past year, CO annual net profit has changed by +$2.99 M (+3.98%)

What is Global Cord Blood quarterly net profit?

The current quarterly net income of CO is $16.47 M

What is the all time high quarterly net income for Global Cord Blood?

Global Cord Blood all-time high quarterly net profit is $21.11 M

What is Global Cord Blood quarterly net income year-on-year change?

Over the past year, CO quarterly net profit has changed by -$3.21 M (-16.32%)

What is Global Cord Blood TTM net profit?

The current TTM net income of CO is $77.97 M

What is the all time high TTM net income for Global Cord Blood?

Global Cord Blood all-time high TTM net profit is $81.19 M

What is Global Cord Blood TTM net income year-on-year change?

Over the past year, CO TTM net profit has changed by +$3.04 M (+4.05%)